Concepedia

Georgi Apriamashvili

GA

Statistics

Publications

6

Citations

474

H-Index

6

Active since

2019

Affiliations

Oncode Institute(Current)

The Netherlands Cancer Institute

Utrecht University

Georgi Apriamashvili is an author at Oncode Institute specializing in cancer immunotherapy, immunology, and antitumor t cell responses.

ORCID

Publications per year

2019–2024

6

Publications

6

Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold

David W. Vredevoogd, Thomas Kuilman, Maarten A. Ligtenberg et al. · Cell · 2019 · 263 citations · Full text

, , +14

Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody–Drug Conjugate and Immune Checkpoint Blockade

Julia Boshuizen, Nora Pencheva, Oscar Krijgsman et al. · Cancer Research · 2021 · 66 citations

, , +17

Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling

Georgi Apriamashvili, David W. Vredevoogd, Oscar Krijgsman et al. · Nature Communications · 2022 · 54 citations · Full text

, , +17

RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells

Zhengkui Zhang, Xiangjun Kong, Maarten A. Ligtenberg et al. · Cell Reports Medicine · 2022 · 44 citations · Full text

, , +17

CRASH-IT Switch Enables Reversible and Dose-Dependent Control of TCR and CAR T-cell Function

Ali Can Sahillioğlu, Mireille Toebes, Georgi Apriamashvili et al. · Cancer Immunology Research · 2021 · 30 citations · Full text

, , +17

1–5 of 6